Current status of Rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractRho-kinase (ROCK) is one of the effectors of the small GTP-binding protein Rho. Accumulating evidence suggests that the Rho/ROCK system may play an important role in the pathogenesis of atherosclerosis and coronary vasospasm via its action in vascular smooth muscle cell contraction, endothelial function and the inflammatory process. Recent observations suggest that the beneficial cardiovascular effects of statins may, at least in part, derive from the inhibition of ROCKs. Fasudil is a ROCKs inhibitor which has potential benefits in coronary artery spasm and myocardial ischemia. In this review, we aim to describe the current understanding of ROCKs signaling and their roles in the pathophysiology of atherosclerosis and coronary spasm. © 2009 Bentham Science Publishers Ltd.
All Author(s) ListDong M., Yan B.P., Yu C.-M.
Journal nameCardiovascular and Hematological Agents in Medicinal Chemistry
Detailed descriptionEpub ahead of print
Year2009
Month10
Day1
Volume Number7
Issue Number4
PublisherBentham Science Publishers
Place of PublicationUnited Arab Emirates
Pages322 - 330
ISSN1871-5257
LanguagesEnglish-United Kingdom
KeywordsAtheroscleorosis, Coronary spasm, Inhibitor, Rho-kinase (ROCK)

Last updated on 2020-21-09 at 01:59